NVO

99.81

1.90% -1.93

Handel nachbörslich: 99.40 -0.41 -0.41%

Novo Nordisk Adr (NVO)

Überblick Nachrichten Preisverlauf Optionskette Warum fällt NVO? Forum Prognose Aktiensplit Dividendenhistorie

Schlusskurs vom Vortag:

$101.74

Offen:

$100.32

24-Stunden-Volumen:

8.50M

Relative Volume:

1.96

Marktkapitalisierung:

$446.14B

Einnahmen:

$39.36B

Nettoeinkommen (Verlust:

$13.79B

KGV:

41.45

EPS:

2.4077

Netto-Cashflow:

$9.83B

1W Leistung:

-8.51%

1M Leistung:

-15.48%

6M Leistung:

-24.32%

1J Leistung:

-1.56%

1-Tages-Spanne:

$99.42

$101.00

1-Wochen-Bereich:

$99.42

$107.79

52-Wochen-Spanne:

$94.73

$148.15

Novo Nordisk Adr Stock (NVO) Company Profile

Firmenname

Novo Nordisk Adr

Sektor

Healthcare (1196)

Branche

Drug Manufacturers - General (18)

Telefon

Adresse

Mitarbeiter

72,000

Twitter

@novonordisk

Nächster Verdiensttermin

2024-12-06

Neueste SEC-Einreichungen

NVO's Discussions on Twitter

Vergleichen Sie NVO mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
NVO	99.81	446.14B	39.36B	13.79B	9.83B	2.4077
LLY	727.20	683.37B	40.86B	8.37B	-2.28B	5.4193
JNJ	154.77	353.35B	87.70B	14.68B	19.03B	13.47
ABBV	166.28	293.80B	55.53B	5.12B	15.62B	3.65
MRK	96.56	242.49B	63.17B	12.15B	14.84B	1.80

Novo Nordisk Adr Stock (NVO) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-05-30	Eingeleitet	Goldman	Buy
2024-04-12	Eingeleitet	BMO Capital Markets	Outperform
2024-01-23	Eingeleitet	Morgan Stanley	Overweight
2024-01-16	Fortgesetzt	UBS	Neutral
2023-12-01	Eingeleitet	Cantor Fitzgerald	Overweight
2023-10-02	Eingeleitet	Argus	Buy
2023-07-14	Eingeleitet	HSBC Securities	Buy
2022-07-15	Hochstufung	Morgan Stanley	Equal-Weight → Overweight
2022-06-28	Herabstufung	UBS	Neutral → Sell
2022-06-27	Hochstufung	Exane BNP Paribas	Underperform → Neutral
2022-06-07	Hochstufung	JP Morgan	Neutral → Overweight
2022-05-31	Hochstufung	Guggenheim	Neutral → Buy
2022-04-25	Hochstufung	Cowen	Market Perform → Outperform
2022-04-12	Hochstufung	Morgan Stanley	Underweight → Equal-Weight
2022-03-16	Hochstufung	Deutsche Bank	Hold → Buy
2022-01-25	Herabstufung	Liberum	Hold → Sell
2021-12-20	Herabstufung	JP Morgan	Overweight → Neutral
2021-12-17	Herabstufung	Deutsche Bank	Buy → Hold
2021-01-20	Herabstufung	Credit Suisse	Outperform → Neutral
2021-01-15	Eingeleitet	Deutsche Bank	Buy
2020-09-29	Eingeleitet	Berenberg	Hold
2020-07-06	Herabstufung	BofA Securities	Buy → Neutral
2020-05-11	Herabstufung	UBS	Buy → Neutral
2020-05-04	Eingeleitet	Cowen	Market Perform
2020-03-16	Hochstufung	BofA/Merrill	Neutral → Buy
2020-01-03	Herabstufung	Guggenheim	Buy → Neutral
2019-11-18	Hochstufung	Barclays	Equal Weight → Overweight
2019-09-17	Hochstufung	Citigroup	Neutral → Buy
2019-08-30	Herabstufung	Jefferies	Hold → Underperform
2019-06-20	Herabstufung	Deutsche Bank	Buy → Hold
2019-06-11	Hochstufung	Barclays	Underweight → Equal Weight
2019-04-29	Hochstufung	Credit Suisse	Neutral → Outperform
2019-01-29	Eingeleitet	Exane BNP Paribas	Outperform
2018-12-11	Fortgesetzt	Jefferies	Hold
2018-10-09	Eingeleitet	Guggenheim	Buy
2017-12-29	Hochstufung	JP Morgan	Underweight → Neutral
2017-12-06	Hochstufung	BofA/Merrill	Neutral → Buy
2017-12-01	Hochstufung	Morgan Stanley	Equal-Weight → Overweight
2017-09-25	Herabstufung	Exane BNP Paribas	Outperform → Neutral
2017-09-06	Hochstufung	BofA/Merrill	Underperform → Neutral

Alle ansehen

Novo Nordisk Adr Aktie (NVO) Neueste Nachrichten

06:03 AM

3 Growth Stocks You Can Buy Right Now Without Any Hesitation - The Motley Fool

06:03 AM

Nov 08, 2024

Biopharma Stock Election Impact: Potential Reduced IRA Headwind but Unpredictable Challenges - Morningstar

Nov 08, 2024

Nov 06, 2024

Novo Nordisk A/S (NVO) Stock Price, News, Quote & History - Yahoo Finance

Nov 06, 2024

NVO Misses Q3 Earnings & Revenue Estimates, Updates 2024 View - Yahoo Finance

Nov 06, 2024

European Equities Traded in the US as American Depositary Receipts Kick Off Week Lower in Monday Trading - MSN

Nov 06, 2024

Novo Nordisk ADR earnings beat by $5.24, revenue topped estimates - Investing.com Australia

Nov 06, 2024

Oct 21, 2024

European Equities Traded in the US as American Depositary Receipts Open Week Slightly Higher - MSN

Oct 21, 2024

India Subcutaneous Drug Delivery Devices Market Size & Outlook, 2030 - Grand View Research

Oct 21, 2024

Oct 18, 2024

Why this money manager sees FirstService, Novo Nordisk and Microsoft as good long-term holdings - The Globe and Mail

Oct 18, 2024

Oct 16, 2024

Monitoring Melco Resorts & Entertainment Ltd ADR (MLCO) after recent insider movements - Knox Daily

Oct 09, 2024

Oct 07, 2024

Weekly Upgrades and Downgrades - InvestorPlace

Oct 07, 2024

Precidian to List First ADRhedged Securities in the U.S. on Cboe - Traders Magazine

Oct 07, 2024

Oct 03, 2024

Novo Nordisk Currently Down Six Consecutive Days, on Pace for Longest Losing Streak Since September 2022 — Data Talk - Morningstar

Oct 03, 2024

Oct 02, 2024